Developing new imaging agents to track reactive oxygen and nitrogen species in the body

Boron-Rich Cluster Materials for Vibrational- and Mass Spectral-Based Bioimaging of Reactive Oxygen/Nitrogen Species

NIH-funded research University of Delaware · NIH-11018378

This study is working on new materials that can help doctors see important signals in the body related to diseases like Alzheimer's and autoimmune disorders, aiming to create better tools for diagnosing and managing these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Delaware NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project IDNIH-11018378 on NIH RePORTER

What this research studies

This research focuses on creating innovative boron-rich cluster materials that can be used for advanced bioimaging techniques to monitor reactive oxygen and nitrogen species (ROS/RNS) in biological systems. By utilizing vibrational spectroscopy and mass spectrometry, the project aims to overcome limitations of traditional fluorescent imaging methods, allowing for more precise tracking of these important biological signals. The goal is to develop sensors that can detect multiple ROS/RNS simultaneously, which are crucial in understanding various diseases, including neurodegenerative and autoimmune conditions. Patients may benefit from improved diagnostic tools that can lead to better management of these diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with neurodegenerative diseases, autoimmune disorders, or conditions associated with oxidative stress.

Not a fit: Patients with conditions unrelated to oxidative stress or those not experiencing neurodegenerative or autoimmune diseases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnostic tools for diseases linked to oxidative stress, improving patient outcomes.

How similar studies have performed: While the use of vibrational spectroscopy and mass spectrometry in bioimaging is emerging, the specific approach of using boron-rich cluster materials for this purpose is relatively novel and has not been extensively tested.

Where this research is happening

Newark, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAutoimmune Diseasesautoimmune disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.